Search results for " Digestive System"

showing 5 items of 125 documents

Duodenal Signet Ring Cell Carcinoma in a Celiac Patient

2009

Celiac disease results from damage to the small intestinal mucosa due to an inappropriate immune response to a cereal protein. Long-standing or ‘refractory’ celiac disease is associated with an increased risk of autoimmunity and malignancy. We produced a brief literature review starting from a case of duodenal cancer in a celiac patient. The patient with an history of celiac disease since six months presented with acute manifestation of gastric outlet syndrome. A duodenal stricture was diagnosed at upper gastrointestinal endoscopy and confirmed by abdominal computed tomography. He was successfully treated by segmental duodenal resection. In the resected specimens, the diagnosis was duodenal…

medicine.medical_specialtySignet ring cellmedicine.medical_treatmentGastroenterologyInternal medicineSignet ring cell carcinomamedicineCeliac diseaselcsh:RC799-869duodenal cancer celiac sprue adenocarcinomabusiness.industrySignet ring cellGastroenterologymedicine.diseasePancreaticoduodenectomyResectiondigestive system diseasesmedicine.anatomical_structureDuodenal adenocarcinomaPublished: April 2009DuodenumDuodenal CarcinomaDuodenal adenocarcinomaSurgerylcsh:Diseases of the digestive system. GastroenterologySegmental resectionDuodenal cancerbusinessCase Reports in Gastroenterology
researchProduct

Síndrome del intestino irritable

2005

medicine.medical_specialtybusiness.industryInternal medicineGastroenterologymedicineMEDLINElcsh:Diseases of the digestive system. GastroenterologyGeneral Medicinelcsh:RC799-869medicine.diseasebusinessGastroenterologyIrritable bowel syndromeRevista Española de Enfermedades Digestivas
researchProduct

Molecular endoscopic imaging: the future is bright

2019

The prediction and final survival rate of gastrointestinal cancers are dependent on the stage of disease. The ideal would be to detect those gastrointestinal lesions at early stage or even premalignant forms which are difficult to detect by conventional endoscopy with white light optical imaging as they show minimum or no changes in morphological characteristics and are thus left untreated. The introduction of molecular imaging has greatly changed the pattern for detecting gastrointestinal lesions from purely macroscopic structural imaging to the molecular level. It allows microscopic examination of the gastrointestinal mucosa with endoscopy after the topical or systemic application of mol…

medicine.medical_specialtyex vivo studyReviewAntibody labeling03 medical and health sciencesEndoscopic imagingconfocal endomicroscopy0302 clinical medicinemedicinelcsh:RC799-869Stage (cooking)endoscopySurvival rateIdeal (set theory)medicine.diagnostic_testbusiness.industryGastroenterologymolecular imagingEndoscopy030220 oncology & carcinogenesislcsh:Diseases of the digestive system. Gastroenterology030211 gastroenterology & hepatologyRadiologyMolecular imagingin vivo imagingbusinessPreclinical imagingantibody labelingTherapeutic Advances in Gastrointestinal Endoscopy
researchProduct

Sentinel Lymph Node Analysis in Colorectal Cancer Patients Using One-Step Nucleic Acid Amplification in Combination With Fluorescence and Indocyanine…

2018

Purpose: Analysis of the sentinel lymph node (SLN) in colorectal cancer (CRC) patients was proposed for more accurate staging and tailored lymphadenectomy. The aim of this study was to assess the ability to predict lymph node (LN) involvement through analysis of the SLN with a one-step nucleic acid (OSNA) technique in combination with peritumoral injection of indocyanine green (ICG) and near-infrared (NIR) lymphangiography in CRC patients. Methods: A total of 34 patients were enrolled. Overall, 51 LNs were analyzed with OSNA. LNs of 17 patients (50%) were examined simultaneously with hematoxylin and eosin (H&E) and OSNA. Results: SLN analysis of 17 patients examined with H&E and OSN…

medicine.medical_specialtyindocyanine greenAdjuvant chemotherapyColorectal cancermedicine.medical_treatmentSentinel lymph nodeH&E staincolorectal cancerRC799-86903 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicinesentinel lymph node analysisLymph nodebusiness.industryGastroenterologyDiseases of the digestive system. Gastroenterologymedicine.diseaseSettore MED/18 - Chirurgia Generalemedicine.anatomical_structurechemistryone-step nucleic acid030220 oncology & carcinogenesisNucleic acidOriginal Article030211 gastroenterology & hepatologySurgeryLymphadenectomyfluorescenceRadiologySentinel lymph node analysibusinessIndocyanine greenAnnals of Coloproctology
researchProduct

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

2021

Background & aims Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety of OCA under real-world conditions. Methods Patients were recruited into the Italian PBC Registry, a multicentre, observational cohort study that monitors patients with PBC at national level. The primary endpoint was the biochemical response according to Poise criteria; the secondary endpoint was the biochemical response according to normal range criteria, defined as normal levels of bilirubin, alkaline phosphatase (ALP), and alanine aminotransfer…

upper limit of normalCirrhosisALTAMAAutoimmunityantinuclear antibodiesULNPBCGastroenterologyUDCASettore MED/12ULN upper limit of normalobeticholic acidaRR adjusted risk ratio.CRFs case record formAST aspartate transferaseClinical endpointGGT gamma-glutamyl transferaseQCprimary biliary cholangitisGastroenterologyUrsodeoxycholic acidANATCCCirrhosisCholestasiTIPSTreatment Completer CohortANA antinuclear antibodiemedicine.medical_specialtyRRUDCA ursodeoxycholic acidTIPS transjugular intrahepatic portosystemic shuntOCACirrhosiALP alkaline phosphataseautoimmune hepatitismedicine.diseasedigestive system diseasesDiscontinuationKeywords: AIH autoimmune hepatitiQC quality controlchemistrygamma-glutamyl transferaserandomised controlled trialelectronic data captureantimitochondrial antibodiesaspartate transferaseAutoimmune hepatitischemistry.chemical_compoundAIHCRFsImmunology and Allergyadjusted risk ratioANA antinuclear antibodiesRR risk ratioOverall cohortALT alanine transferaseAMA antimitochondrial antibodieCholestasisCRFs case record formsObeticholic acidOverlap PBC-AIHursodeoxycholic acidOCA obeticholic acidTolerabilityalkaline phosphataseRCTResearch Articlemedicine.drugcase record formsContext (language use)AMA antimitochondrial antibodiesInternal medicineEDC electronic data capturetransjugular intrahepatic portosystemic shuntInternal MedicinemedicineRCT randomised controlled trialaRR adjusted risk ratioOClcsh:RC799-869quality controlalanine transferaseASTaRRHepatologybusiness.industryAutoimmunity; Cholestasis; Cirrhosis; Overlap PBC-AIHAIH autoimmune hepatitisTCC Treatment Completer CohortPBC primary biliary cholangitiGGTrisk ratioOC Overall cohortALPlcsh:Diseases of the digestive system. GastroenterologyPBC primary biliary cholangitisbusinessEDC
researchProduct